Skip to main content
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. — Investor Relations & Filings

Ticker · HRMY ISIN · US4131971040 US Manufacturing
Filings indexed 416 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country US United States of America
Listing US HRMY

About Harmony Biosciences Holdings, Inc.

https://www.harmonybiosciences.com/

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for rare neurological diseases. The company addresses areas of significant unmet medical need, with a primary focus on sleep/wake disorders. Its patient-focused drug development model uses patient insights to inform clinical research programs. Harmony Biosciences markets an FDA-approved product and is dedicated to expanding its portfolio to deliver innovative treatments for individuals living with overlooked neurological conditions.

Recent filings

Filing Released Lang Actions
8-K - Harmony Biosciences Holdings, Inc. (0001802665) (Filer)
Regulatory Filings
2026-05-07 English
10-Q - Harmony Biosciences Holdings, Inc. (0001802665) (Filer)
Interim / Quarterly Report
2026-05-07 English
8-K - Harmony Biosciences Holdings, Inc. (0001802665) (Filer)
Regulatory Filings
2026-04-14 English
ARS - Harmony Biosciences Holdings, Inc. (0001802665) (Filer)
Annual Report
2026-04-03 English
DEF 14A - Harmony Biosciences Holdings, Inc. (0001802665) (Filer)
Proxy Solicitation & Information Statement
2026-04-03 English
8-K - Harmony Biosciences Holdings, Inc. (0001802665) (Filer)
Regulatory Filings
2026-04-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.